1. Home
  2. RGP vs SGMO Comparison

RGP vs SGMO Comparison

Compare RGP & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$3.77

Market Cap

151.8M

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.45

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
SGMO
Founded
1996
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.8M
141.2M
IPO Year
2000
2000

Fundamental Metrics

Financial Performance
Metric
RGP
SGMO
Price
$3.77
$0.45
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$6.00
$5.75
AVG Volume (30 Days)
463.9K
8.1M
Earning Date
04-06-2026
05-11-2026
Dividend Yield
7.59%
N/A
EPS Growth
N/A
66.89
EPS
N/A
N/A
Revenue
$551,331,000.00
$36,567,000.00
Revenue This Year
N/A
$4.79
Revenue Next Year
$1.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
88.60
52 Week Low
$3.42
$0.35
52 Week High
$7.41
$1.06

Technical Indicators

Market Signals
Indicator
RGP
SGMO
Relative Strength Index (RSI) 38.43 55.11
Support Level N/A $0.43
Resistance Level $4.86 $0.48
Average True Range (ATR) 0.18 0.04
MACD -0.02 0.01
Stochastic Oscillator 36.41 46.41

Price Performance

Historical Comparison
RGP
SGMO

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: